The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Public ClinicalTrials.gov record NCT07142304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy. The Lilac Glove and Boot devices apply a low pressure across the surface of the hands and feet, respectively, to reduce access of chemotherapy to the peripheral nerves on the hands and feet. The small amount of pressure reduces the level of chemotherapy reaching the peripheral nerves, hence increasing the likelihood of nerve preservation during treatment and thus may potentially temporarily prevent the onset of moderate to severe PN symptoms induced by chemotherapy in the hands and feet while receiving treatment
Study identification
- NCT ID
- NCT07142304
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 142 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Sep 30, 2026
- Last update posted
- Jun 9, 2026
2025 – 2026
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palomar Health (Topography) | Poway | California | 92064 | Withdrawn |
| Eastern Connecticut Hematology Oncology | Norwich | Connecticut | 06360 | Recruiting |
| Hialeah Hospital | Hialeah | Florida | 33013 | Recruiting |
| Hawaii Cancer Care | Honolulu | Hawaii | 96813 | Recruiting |
| Hope and Healing Cancer Services | Hinsdale | Illinois | 60521 | Recruiting |
| Parkview Cancer Institute | Fort Wayne | Indiana | 46845 | Recruiting |
| Health Partners Frauenshuh Cancer Center | Minneapolis | Minnesota | 55426 | Recruiting |
| Fairview Masonic Cancer Clinic, University of Minnesota | Minneapolis | Minnesota | 55455 | Recruiting |
| Astera Cancer Care | East Brunswick | New Jersey | 08816 | Recruiting |
| Inspira Medical Center Mullica Hill | Mullica Hill | New Jersey | 08062 | Recruiting |
| Inspira Health - Vineland | Vineland | New Jersey | 08360 | Recruiting |
| New York Cancer and Blood Specialists | New York | New York | 11967 | Recruiting |
| Springfield Regional Cancer Center | Springfield | Ohio | 45502 | Recruiting |
| Mercy Health St. Elizabeth Hospital | Youngstown | Ohio | 44512 | Recruiting |
| Providence Cancer Institute | Portland | Oregon | 97213 | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | Recruiting |
| Hospital Sisters Health System - St.Vincent & St.Mary's | Green Bay | Wisconsin | 54301 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07142304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07142304 live on ClinicalTrials.gov.